PharmAust’s wholly owned synthetic and medicinal chemistry subsidiary, Epichem, is set to further improve its bottom line after paying off the $750,000 loan from Export Finance Australia taken out to help finance the construction of a state-of-the-art laboratory in 2015. This laboratory fuelled growth over the period from 2015 to 2018, with revenues increasing 38% to $3 million in the 2018 financial year.
05/07/2019 - 09:03
PharmAust subsidiary repays debt on first laboratory
By Matt Birney
05/07/2019 - 09:03
Related Data & Insights
-
-
Rank Company Revenue 128th PharmAust $3.8m 137th Adisyn $2.9m 138th rent.com.au $2.8m 141st Douugh $2.5m 142nd Hazer Group $2.4m 201 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Data & Insights
Mentioned Organisations
Mentioned People
Related Articles
05 Feb 2024
Board Moves February 5, 2024
28 Aug 2023
Board Moves August 28, 2023
Subscribe today for award-winning, unbiased and trusted journalism
Subscription OptionsX